Survey
* Your assessment is very important for improving the workof artificial intelligence, which forms the content of this project
* Your assessment is very important for improving the workof artificial intelligence, which forms the content of this project
CASE REPORT Milliary Tuberculosis with Unusual Paradoxical Response at 3 Weeks of Antituberculous Treatment Liaqat Ali Chaudhry1, Ebtesam Ba-Essa2 and Shehab Al-Solaiman2 ABSTRACT Milliary Tuberculosis (TB) occurs through lymphohaematogenous dissemination of M. tuberculosis and paradoxical response (PR) is a recognized feature. Respiratory failure, choroid tubercles and brain tuberculomas are some of the complications. Brain tuberculomas mainly occur in the cerebrum, cerebellum, where as involvement of the brainstem is rare. A 31 years old female presented with history of ill health, easy fatigability, excessive sweating and fever of one month duration, dry cough for one week and shortness of breath for 3 days. Provisional diagnosis was disseminated TB complicated by hypoxemic respiratory failure and bilateral choroid tubercles. She was started on anti-TB treatment with adjuvant steroids. The initial response to treatment was remarkable but after about 3 weeks of anti-TB therapy, she suddenly deteriorated developing spastic ataxia. After exclusion of other possible causes she was successfully treated under the impression of having PR. Key words: Disseminated tuberculosis. Pyrexia of unknown origin (PUO). Choroid tubercles. Tuberculomas. Paradoxical reaction (PR). Paraparesis. AFB -Acid fast bacteria. INTRODUCTION Disseminated tuberculosis is defined as tuberculous infection caused by Mycobacterium tuberculosis bacilli spreading via lymphohaematogenous route to more than two non-contiguous sites. PR is a recognized feature in about 25% patients of TB with or without HIV, defined by a clinical or radiological worsening of preexisting tuberculous lesions or the development of new lesions in patients receiving anti-TB drugs who initially improved on treatment. Central nervous system is the commonest system affected.1-4 We present a case of disseminated TB who manifested severe spastic ataxia as a manifestation of PR at 3 weeks of anti-TB treatment despite being on 2 weeks adjuvant steroids from day one. CASE REPORT A previously healthy Indonesian female aged 31 years presented with fatigability, excessive sweating and fever especially in the afternoons of one month duration, dry cough for one week and shortness of breath for 3 days. There was no history of contact with infectious patient. Department of Medicine and Chest Diseases1 / Medicine2, Dammam Medical Complex (MOH), Dammam, Kingdom of Saudi Arabia. Correspondence: Dr. Liaqat Ali Chaudhry, Consultant Pulmonologist and Acting Chairman of Internal Medicine, Sultan Bin Abdulaziz Humanitarian City and Medical Centre, P.O. Box 64399, Riyadh 11536, Qasim Highway, North Exit 6, Banban, Kingdom of Saudi Arabia. E-mail: [email protected] Received September 24, 2010; accepted November 28, 2011. She denied family history of tuberculosis, surgery, blood transfusion, or high risk behaviour. At the time of admission she was alert and ambulant with blood pressure of 116/77 mmHg, 110/minute, o temperature of 38 C, respiratory rate of 26 breaths/ minute O2 saturation 87% at room air and weighing 42.2 kg. On chest auscultation, she had occasional bilateral fine crackles, and bilateral choroid lesions on fundoscopy (Figures 1 and 2). Patient denied any visual complaints, and rest of the systemic examination was unremarkable. Sputum Zeihl Nelson direct smear was AFB positive. Arterial blood gas (ABG) analysis at room air showed pH of 7.4, PaCO2 of 32 mmHg, PaO2 was 51.7 mmHg, HCO3 was 23 and O2 saturation was 86.4. Sputum culture sensitivity reported M. tuberculosis sensitive to all drugs. Blood chemistry and haematology was normal. ESR was 65 mm after first hour. Hepatitis B, C and HIV serology were negative. CSF showed lymphocytic predominance (78%) and raised proteins (2.3 mg/dl) and low glucose (41 mg/dl). CSF PCR +ve for M. tubercolosis but culture was AFB negative. Chest X-ray showed bilateral miliary shadows. Having disseminated TB involving lungs, complicated with respiratory failure and bilateral choroid eye lesions, she was started “DOTS” with INH 200 mg once daily, Pyridoxine 20 mg once daily, Rifampicin 450 mg once daily, Pyrazinamide 1250 mg once daily, Ethambutol 600 mg once daily, Injection Methylprednisolone 40 mg I/V 12 hourly, Pantoprazole 20 mg HS, Paracetamol 500 mg 2 tablets 8 hourly only. She required 1-2 L/min of O2 by nasal cannula only. Journal of the College of Physicians and Surgeons Pakistan 2012, Vol. 22 (1): 43-45 43 Liaqat Ali Chaudhry, Ebtesam Ba-Essa and Shehab Alsolaiman Figure 1: Choroid lesions in the left eye. Figure 2: Choroid lesions in the right eye . She tolerated treatment well and after one week her ABG’s at room air became normal. Steroids were now switched to oral prednisolone 40 mg /day. After 10 days of treatment her temperature subsided. Prednisolone was tapered off. After 22 days of treatment, she complained of feeling heaviness of her feet and difficulty in walking. Within 2 days she became bed bound and neurological examination revealed spastic paraparesis. Coordination and sensations were normal, bowel and bladder control was intact, while upper limbs were normal. An urgent MRI of brain and spine (Figure 3) revealed multiple tuberculomas of the brain involving cerebral cortex, cerebellum and brainstem. Her sputum culture being positive for typical Mycobacterium and sensitive to all first line drugs. She was treated by DOTS method. Initial clinical, radiological and finally bacteriological response to initial 4 drug anti-TB and adjuvant steroids treatment was remarkable, thus her ataxia was due to PR. She improved in response to the same anti-TB drugs with re-introduction of steroids. She received Dexamethasone 4 mg IV 8 hourly in the first week, and 4 mg IV 12 hourly during the second week. Afterwards, it was changed to oral Prednisolone 40 mg once daily. After 41 days of treatment, her sputum direct AFB was reported negative 3 times. On completion of 46 days of treatment patient showed signs of improvement and was able to walk with Zimmer's frame. Prednisolone was tapered off and rest of the treatment continued including physiotherapy. After she completed 54 days of treatment and her sputum direct smear AFB was reported 3 times negative, she was discharged home on the request of her sponsor. She left for her home country and could not be followed. DISCUSSION Paradoxical reaction (PR) in tuberculosis (TB) is common and may affect upto 25% of patients. Among patients having tuberculosis with HIV negative status in Taiwan the reported incident of PR has been 2.4%.5 PR has the potential to cause significant morbidity and, on 44 Figure 3: Sagittal contrast enhanced MRI showing enhancing lesions in brainstem. rare occasions, death. Although PR has been recognised for some time, the pathophysiology, especially in HIVnegative patients, is not well understood. Central nervous system is the commonest system affected in about 75% of cases. Diagnosis of PR is based on excluding various secondary causes like poor compliance, drug resistance, HIV status, anti-retroviral therapy, drug fever and progression of original disease. The incidence, timing and clinical spectrum of PR vary widely. Associated risk factors and predisposition to PR has not been well understood. A rise in lymphocyte count, tuberculin conversion during treatment and disseminated disease may all be associated with the development of PR.6 This patient was active, ambulant and her neurological examination was unremarkable at the time of admission. She responded very well to initial treatment. But after completion of 3 weeks of anti-TB treatment she developed spastic ataxia of both lower limbs, it was an unusual manifestation of paradoxical deterioration despite 2 weeks adjuvant steroids from day one. Diagnosis of PR is mainly by exclusion of various causes like non-compliance, unexpected drug resistance, malabsorption, immunodeficiency and antiretroviral therapy which was absent in this patient. The clinical picture was also contrary to a drug fever, as this patient remained afebrile and had evidence of central nervous system involvement, which refuted drug fever. The picture was that of a paradoxical reaction which responded to same anti-TB drugs with re-introduction of adjuvant steroids. PR is due to detonation of existing lesions in large majority of patients but in minority of patients it could be due to development of new lesions. Response to steroids is typical as observed in this case. Standard therapeutic guidelines on corticosteroids for tuberculosis do not exist, but Dexamethasone (adults 12-16 mg/day for 3 weeks, tapered over next 3 weeks) or Prednisolone (for adults 60 mg/day for 3 weeks and tapered over 3 weeks) is recommended.7 In this case intravenous Dexamethasone was used at a dose of 12 mg/day for the first week, and tapered over as twice Journal of the College of Physicians and Surgeons Pakistan 2012, Vol. 22 (1): 43-45 Milliary tuberculosis with unusual paradoxical response REFERENCES daily (8 mg/day) for the second week. Afterwards oral Prednisolone was continued at 40 mg/day. 1. This case was unique in the sense that despite having disseminated tuberculosis involving lungs, eyes and brain she did not present with any neurological complaints initially. Other feature was brainstem lesions which is a rare finding. Above all, it is interesting to note that she received anti-TB drugs and adjuvant steroids in the first 2 weeks of treatment from day one for having respiratory failure, but soon after her steroids were tapered she manifested PR at 3 weeks of treatment. This is unusual and exceptional. We would like to share this observation for further debate to reach a consensus on the dose and duration of adjuvant steroids once they are started in a particular patient having disseminated TB. Moreover, this observation has given rise to an interesting question regarding the place for prophylactic adjuvant steroid treatment in anticipation of PR in patients having disseminated TB. l l l l l Wang JY, Hsueh PR, Wang SK, Jan IS, Lee LN, Liaw YS. et al. Disseminated tuberculosis: a 10-year experience in a medical centre, Medicine (Baltimore) 2007; 86:39-46. 2. Guzel A, Tatli M, Aluclu U,Yalcin K. Intracranial multiple tuberculomas: 2 unusual cases. Surg Neurol 2005; 64:S109-12. 3. Idris MN, Sokrab TE, Arbab MA, Ahmed AE, El Rasoul H, Ali S, et al. Tuberculoma of the brain: a series of 16 cases treated with anti-tuberculous drugs. Int J Tuberc Lung Dis 2007; 11:91-5. 4. Varma D, Anand S, Reddy AR, Das A, Watson JP, Currie DC, et al. Tuberculosis an under-diagnosed aetiological agent in uveitis with an effective treatment. Eye (Lond) 2006; 20:1068-73. Epub 2005 Oct 7. 5. Cheng SL, Wang HC, Yang PC. Paradoxical response during anti-tuberculosis treatment in HIV-negative patients with pulmonary tuberculosis. Int J Tuberc Lung Dis 2007; 11:1290-5. 6. Bloch S, Wickremasinge M, Wright A, Rice A, Thompson M, Kon OM. Paradoxical reactions in non-HIV tuberculosis presenting as endobronchial obstruction. Eur Respir Rev 2009; 18:295-9. 7. Prasad K, Singh MB. Corticosteroids for managing tuberculous meningitis. Cochrane Database Syst Rev 2008; (1):CD002244. O l l l l l Journal of the College of Physicians and Surgeons Pakistan 2012, Vol. 22 (1): 43-45 45